Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Maternal acellular pertussis vaccination in mice impairs cellular immunity to Bordetella pertussis infection in offspring
Violaine Dubois, Jonathan Chatagnon, Manon Depessemier, Camille Locht
Violaine Dubois, Jonathan Chatagnon, Manon Depessemier, Camille Locht
View: Text | PDF
Research Article Infectious disease Vaccines

Maternal acellular pertussis vaccination in mice impairs cellular immunity to Bordetella pertussis infection in offspring

  • Text
  • PDF
Abstract

Given the resurgence of pertussis, several countries have introduced maternal tetanus, diphtheria, and acellular pertussis (aP) vaccination during pregnancy to protect young infants against severe pertussis. Although protective against the disease, the effect of maternal aP vaccination on bacterial colonization of the offspring is unknown. Here, we used a mouse model to demonstrate that maternal aP immunization, either before or during pregnancy, protects pups from lung colonization by Bordetella pertussis. However, maternal aP vaccination resulted in significantly prolonged nasal carriage of B. pertussis by inhibiting the natural recruitment of IL-17–producing resident memory T cells and ensuing neutrophil influx in the nasal tissue, especially of those with proinflammatory and cytotoxic properties. Prolonged nasal carriage after aP vaccination is due to IL-4 signaling, as prolonged nasal carriage is abolished in IL-4Rα–/– mice. The effect of maternal aP vaccination can be transferred transplacentally to the offspring or via breastfeeding and is long-lasting, as it persists into adulthood. Maternal aP vaccination may, thus, augment the B. pertussis reservoir.

Authors

Violaine Dubois, Jonathan Chatagnon, Manon Depessemier, Camille Locht

×

Figure 6

Role of the IL-4 pathway in prolonged nasal B. pertussis carriage in aP-immunized BALB/c mice.

Options: View larger image (or click on image) Download as PowerPoint
Role of the IL-4 pathway in prolonged nasal B. pertussis carriage in aP-...
(A) Concentrations of IL-4 and IL-13 in the serum of neonates born to aP-immunized (aP) or control mice (Ctr) 5 days after challenge. (B and C) Six- to 8 week-old BALB/c and IL-4Ra–/– (KO) mice, were immunized twice s.c. with 1/10 human dose of aP or PBS and then challenged with 1 × 106 CFU B1917 (B). Neonates were nasally infected with 5 × 103 CFU B1917 (C). Bacterial burden was determined by CFU counting on homogenized lungs (upper panels) and noses (lower panels) at indicated time points after challenge. (D) Absolute numbers of T cells (left panel), IL-17+ T cells (middle left panel), neutrophils (middle right panel), and APCs (right panel) in the noses of aP (red dots) and control (black dots) IL-4Rα–/– mice 28 dpc. Results shown are geometric means ± SD. n = 5. Mann-Whitney tests were performed to compare Ctr and aP offspring and control KO with aP mice and aP KO mice. *P < 0.05; **P < 0.01.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts